Hypoglycemic imidazoline compounds

US6410562B1 · kind B1 · utility

Assignee

• ELI LILLY AND COMPANY · US

Inventors

• Michael R. Jirousek · Cambridge, US
• Michael Paal · Hamburg, DE
• Gerd Ruhter · Hamburg, DE
• Theo Schotten · Winsen (Luhe), DE
• Kumiko Takeuchi · Indianapolis, US
• Wolfgang Stenzel · Reinbek, DE

Key dates

• Filing date: Dec 8, 2000
• Grant date: Jun 25, 2002
• Expiry date: Dec 8, 2020

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

This invention relates to certain novel imidazoline compounds and analogues thereof, to their use for the treatment of diabetes, diabetic complications, metabolic disorders, or related diseases where impaired glucose disposal is present, to pharmaceutical compositions comprising them, and to processes for their preparation.